Phenazone
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| |
| Phenazone
| |
| Systematic (IUPAC) name | |
| 1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | N02 |
| PubChem | |
| Chemical data | |
| Formula | C11H12N2O |
| Mol. mass | 188.226 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Phenazone | |
|
Articles | |
|---|---|
|
Most recent articles on Phenazone | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Phenazone at Clinical Trials.gov Clinical Trials on Phenazone at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Phenazone
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Phenazone Discussion groups on Phenazone Directions to Hospitals Treating Phenazone Risk calculators and risk factors for Phenazone
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Phenazone | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Phenazone, or phenazon, is an analgesic. It is formed by reducing diortho-dinitrodiphenyl with sodium amalgam and methyl alcohol, or by heating diphenylene-ortho-dihydrazine with hydrochloric acid to 150 C. It crystallizes in needles which melt at 156 C. Potassium permanganate oxidizes it to pyridazine tetracarboxylic acid.
Synonyms
Analgesine, Antipyrine, Diméthyloxyquinazine, Oxydiméthylquinazine, Oxydiméthylquinizine, Pyrazoline
See also
Chimic Class
- Pyrazole
- Pyrazolinone
Pharmacology
Adverse effects
- Allergy to pyrazolones
- Nausea
- Agranulocytosis
WikiDoc Research Resources for Phenazone | |
|---|---|
| Articles on Phenazone | Most recent articles on Phenazone • Most cited articles on Phenazone • Review articles on Phenazone • Articles on Phenazone in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Phenazone | Powerpoint slides on Phenazone • Images of Phenazone • Photos of Phenazone • Podcasts & MP3s on Phenazone • Videos on Phenazone |
| Evidence Based Medicine Regarding Phenazone | Cochrane Collaboration on Phenazone • Bandolier on Phenazone • TRIP on Phenazone |
| Cost Effectiveness of Phenazone | Cost Effectiveness of Phenazone |
| Clinical Trials Involving Phenazone | Ongoing Trials on Phenazone at Clinical Trials.gov • Trial results on Phenazone • Clinical Trials on Phenazone at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Phenazone | US National Guidelines Clearinghouse on Phenazone • NICE Guidance on Phenazone • NHS PRODIGY Guidance • FDA on Phenazone • CDC on Phenazone |
| Textbook Information on Phenazone | Books and Textbook Information on Phenazone |
| Pharmacology Resources on Phenazone | Dosing of Phenazone • Drug interactions with Phenazone • Side effects of Phenazone • Allergic reactions to Phenazone • Overdose information on Phenazone • Carcinogenicity information on Phenazone • Phenazone in pregnancy • Pharmacokinetics of Phenazone • |
| Genetics, Pharmacogenomics, and Proteinomics of Phenazone | Genetics of Phenazone • Pharmacogenomics of Phenazone • Proteomics of Phenazone |
| Newstories on Phenazone | Phenazone in the news • Be alerted to news on Phenazone • News trends on Phenazone |
| Commentary on Phenazone | Blogs on Phenazone |
| Patient Resources on Phenazone | Patient resources on Phenazone • Discussion groups on Phenazone • Patient Handouts on Phenazone • Directions to Hospitals Treating Phenazone • Risk calculators and risk factors for Phenazone |
| Healthcare Provider Resources on Phenazone | Symptoms of Phenazone • Causes & Risk Factors for Phenazone • Diagnostic studies for Phenazone • Treatment of Phenazone |
| Continuing Medical Education (CME) Programs on Phenazone | CME Programs on Phenazone |
| International Resources on Phenazone | Phenazone en Espanol • Phenazone en Francais |
| Business Resources on Phenazone | Phenazone in the Marketplace • Patents on Phenazone |
| Informatics Resources on Phenazone | List of terms related to Phenazone |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
